In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030

In Silico Drug Discovery Services Market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Presently,in silico tools / approaches are available for the identification, selectionand optimization of pharmacological leads. in fact, the predictive power ofsuch solutions has been demonstrated to enable researchers to bypass thetraditional experimental screening of billions of molecules against hundreds ofbiological targets, thereby, allowing significant reductions in the investmentof both time and resources.

TheUSD 124 million (by 2030) financial opportunity within the in Silico Drug Discovery Market for large molecules has been analyzedacross The following segments:

KeyDrug Discovery Steps

·       Target Identification

·       Target Validation

·       Hit Generation

·       Hit-to-Lead

·       Lead Optimization 

Typeof Large Molecule

·       Antibodies

·       Proteins

·       Peptides

·       Nucleic Acids

·       Vectors

CompanySize

·       Small

·       Mid-sized

·       Large

Targettherapeutic Area

·       Autoimmune Disorders

·       Blood Disorders

·       Cardiovascular Disorders

·       Gastrointestinal and Digestive Disorders

·       Hormonal Disorders

·       Human Immunodeficiency Virus (HIV) / AcquiredImmunodeficiency Syndrome (AIDS)

·       Infectious Diseases

·       Metabolic Disorders

·       Mental Disorders

·       Musculoskeletal Disorders

·       Neurological Disorders

·       Oncological Disorders

·       Respiratory Disorders

·       Skin Disorders

·       Urogenital Disorders

·       Others

Typeof Sponsor

·       Industry Players

·       Non-Industry Players

KeyGeographical Regions

·       North America

·       Europe

·       Asia-Pacific

Requestfor Customization: https://www.rootsanalysis.com/reports/298/request-customization.html

TheIn Silico / Computer-Aided Drug Discovery Services Market: Focus on LargeMolecules, 2020-2030, report features the following companies, which weidentified to be key players in this domain:   

·       Abzena

·       BioDuro

·       BioNTech

·       ChemPartner

·       Creative Biostructure

·       GenScript

·       LakePharma

·       Sundia MediTech

·       Sygnature Discovery

·       Viva Biotech

Tableof Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Key Insights

6. Company Profiles

7. Company Competitiveness Analysis

8. Key Opportunity Areas

9. Emerging Business Models and Strategies

10. Case study: comparison of drug discovery processes ofsmall molecules     and large molecules

11. Survey insights

12. Cost saving analysis

13. Market Forecast

14. In silico tools and upcoming trends in drug discovery

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

18. Appendix 3: Non-Computational Methods for DrugDiscovery

Requestfor PDF Sample:

https://www.rootsanalysis.com/reports/298/request-sample.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com